More serious side effects can include pancreatitis, kidney problems, and thyroid tumors, although these are rare
Exenatide, the active ingredient in Bydureon BCise, was the first GLP-1 medication to be approved by the FDA
In case more than two doses are continuously missed, resume the next dose or restart the dose escalation
At this concentration, reaching the standard starting dose of 0.25 mg requires drawing 25 units
Serious side effects to look for include unexplained rectal bleeding, persistent abdominal pain, sudden weight loss, or changes in bowel habits that lead to a cancer diagnosis
Product Specifications CAS Number: 910463-68-2 Synonym: NN9535 Peptide Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc--Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH Molecular Formula: CHNO Molecular Weight: 6 g/mol Purity: 95% (verified by HPLC and mass spectrometry) Packaging Format: 5 mg lyophilized powder in sealed research-grade vial Storage Conditions: Store 28 C (20 C long term)
